OR WAIT 15 SECS
ST. PAUL, Minn. -- 3M Health Care announces a licensing agreement with ClozeX Medical LLC, a provider of unique skin closure devices to treat lacerations and close surgical incisions. The agreement gives 3M exclusive worldwide rights for the manufacturing and distribution of ClozeX Wound Closures.
The license agreement builds on 3M Health Care's reputation and global presence in surgical and wound care products. "Adding the ClozeX family of products to 3M Health Care's existing wound closure portfolio provides a time-saving option to surgeons and other medical specialists for painless, needleless closure of surgical incisions and lacerations," said Dr. J. Michael McQuade, division vice president with 3M Medical Division. "The licensing agreement allows us to combine innovative ClozeX technology with 3M's expertise in wound care to deliver easy-to-use, skin-friendly solutions to surgeons and clinicians."
A variety of surgeons and physicians in different medical specialties currently use ClozeX Wound Closures in surgery. These include plastic and reconstruction, cardiothoracic, vascular, OB-GYN, general surgery, orthopedics, dermatology and emergency medicine. Response has been positive to the time savings, ease of use and cosmetic benefits.
ClozeX Medical LLC of Wellesley, Mass., is a privately-held company developing innovative wound closure products for more than eight years. Michael Lebner, the company's founder and president said, "We believe ClozeX is the next generation of primary skin closures. Our company's efforts have been rewarded with a transaction that merges our unique and superior technology with 3M Health Care's market leadership to improve wound closure for millions worldwide."
Source: 3M Health Care